The Prognostic Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Resected Patients with Pancreatic Adenocarcinoma

World Journal of Surgery
Le-Ping FangPu-Wen Huang

Abstract

This research aims to analyze neutrophil-to-lymphocyte ratio (NLR) for resectable pancreatic ductal adenocarcinoma (PDAC) patients and reveal its predictive value. We enrolled 389 pancreatic adenocarcinoma patients who had undergone curative surgery between January 1, 2008 and August 15, 2015 in Jiangsu Provincial People's Hospital, and they were followed up until December 20, 2016. Among them, 219 patients had definite recurrence record in our hospital. The appropriate cutoff value for the NLR was obtained from X-tile software. The association between qualitative variables and NLR was analyzed by Chi-square test or Fisher's exact test, and for quantitative values, the association was analyzed by independent Student's t test. Additionally, survival analysis was performed by Kaplan-Meier plots. Independent prognostic factors were found according to Cox regression analysis. Based on univariate analysis, the elevated preoperative NLR had an important influence on the decreased recurrence-free survival (RFS) (8.2 vs. 14.9 months) and overall survival (OS) (13.7 vs. 22 months), and this result also counted in the multivariate analysis. Regarding OS, both patients with or without postoperative chemotherapy can obtain benefits from lo...Continue Reading

References

Mar 7, 2001·Lancet·F Balkwill, A Mantovani
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert L CampDavid L Rimm
Mar 18, 2008·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·E J ClarkR W Parks
Jul 25, 2008·Nature·Alberto MantovaniFrances Balkwill
May 12, 2009·International Journal of Cancer. Journal International Du Cancer·Braedon McDonaldLorenzo E Ferri
Sep 25, 2009·Trends in Immunology·Ingrid MüllerGertrud Maria Hänsch
Jan 19, 2010·Nature Medicine·A McGarry HoughtonSteven D Shapiro
Dec 14, 2011·The Journal of Clinical Investigation·Janesh PillayLeo Koenderman
Aug 30, 2014·World Journal of Gastroenterology : WJG·Kristin S InmanNicole R Murray
Mar 12, 2015·World Journal of Gastroenterology : WJG·Jian-Jun YangSheng-Guang Yuan
Jun 2, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alok A KhoranaMatthew H G Katz
Sep 26, 2016·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·He ChengChen Liu
Feb 22, 2017·World Journal of Gastrointestinal Pharmacology and Therapeutics·Gurshawn SinghZeeshan Ramzan
Feb 13, 2018·Hepatobiliary & Pancreatic Diseases International : HBPD INT·Efstathios T Pavlidis, Theodoros E Pavlidis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.